Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
EMR.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
-0.01
vs -0.00
Q4.20
N/A
-0.02
vs -0.00
Q2.21
N/A
-0.02
vs -0.01
Q4.21
+241%
0.02
vs -0.02
Q2.22
+438%
0.06
vs -0.02
Q4.22
+88%
0.04
vs 0.02
Q2.23
+35%
0.08
vs 0.06
Q4.23
+75%
0.07
vs 0.04
Q2.24
-19%
0.06
vs 0.08
Q4.24
+24%
0.09
vs 0.07
Sales Growth
YoY
Current
Estimates
Q2.20
-32%
149K vs 218K
Q4.20
-8%
84K vs 91K
Q2.21
-140%
-60000.00 vs 149K
Q4.21
+75548%
63.5M vs 84K
Q2.22
+238308%
142.9M vs -60000
Q4.22
+109%
133.1M vs 63.5M
Q2.23
+15%
164.6M vs 142.9M
Q4.23
+31%
174.7M vs 133.1M
Q2.24
+18%
194.4M vs 164.6M
Q4.24
+37%
240M vs 174.7M
Return on Equity
QoQ
Q2.21
-8%
-0.08
vs -0.07
Q4.21
+8%
0.08
vs -0.08
Q2.22
+14%
0.14
vs 0.08
Q4.22
+10%
0.1
vs 0.14
Q2.23
+14%
0.14
vs 0.1
Q4.23
+11%
0.11
vs 0.14
Q2.24
+7%
0.07
vs 0.11
Q4.24
+9%
0.09
vs 0.07
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
EMR.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How EMR.AX compares to sector?